Mealey's (April 17, 2020, 8:50 AM EDT) -- NEW YORK — A New York federal judge on March 24 dismissed with leave to amend a false claims complaint alleging that Novartis Pharmaceuticals Corp. used a sham speaker program to pay kickbacks to doctors to prescribe the multiple sclerosis drug Gilenya (United States, ex rel. Steven M. Camburn v. Novartis Pharmaceuticals Corporation, No. 13-3700, S.D. N.Y., 2020 U.S. Dist. LEXIS 52914)....